Global Liquid Biopsy Market Insights 2029: Drivers, Challenges, and Revenue Forecast
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Liquid Biopsy Industry By 2029?
The size of the liquid biopsy market has expanded significantly in the past few years. The market valuation is projected to escalate from $1.25 billion in 2024 to $1.46 billion in 2025, with an impressive compound annual growth rate (CAGR) of 16.1%. Factors contributing to the previous growth include advancements in cancer studies, non-intrusiveness, custom-tailored treatments, regulatory endorsements, and the ability to detect cancer in its early stages.
Over the coming years, the liquid biopsy market size is predicted to experience swift expansion. With a projected compound annual growth rate (CAGR) of 16.7%, it is estimated to reach $2.7 billion by 2029. The anticipated growth during the forecasted period is largely due to increasing applications in cancer monitoring, the advent of new technologies, companion diagnostics, and biomarker discovery. The prominent trends for the forecast period incorporate cancer detection and monitoring, therapeutic monitoring, monitoring of minimal residual disease (mrd), and the application of liquid biopsy in non-oncological areas.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp
Which Industry Forces Are Driving The Liquid Biopsy Market Forward?
The growth of the liquid biopsy market is propelled by government funding aimed at enhancing cancer detection methods. Such funds play a crucial role in assisting researchers with drug discovery, diagnosis, and treatments pertaining to diseases like Cancer. For instance, in 2022, the US-based National Institute of Health (NIH) was the recipient of a $46.6 billion grant. Furthermore, the National Cancer Institute (NCI), an American agency focused on cancer research, was allocated $6.9 billion to progress its work in cancer research. Consequently, this type of government funding creates a positive impact on the expansion of the liquid biopsy market.
What Is The Segment Breakdown Of The Liquid Biopsy Market?
The liquid biopsymarket covered in this report is segmented –
1) By Product: Assays Kits; Instruments; Services
2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics
3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
Subsegments:
1) By Assays Kits: cfDNA Assays; ctDNA Assays; Exosome-based Assays; RNA-based Assays; Protein-based Assays
2) By Instruments: PCR Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; Mass Spectrometry Instruments
3) By Services: Testing Services; Data Analysis Services; Laboratory Services; Custom Assay Development Services
What Are The Dominant Trends Currently Seen In The Liquid Biopsy Market?
Firms are swiftly adjusting to changing market trends and focusing on introducing innovative products, aiming to cater to the continually growing demand for liquid biopsy products and services, enhance their earnings, and establish a competitive advantage over their opponents. For instance, Laboratory Corporation of America Holdings, a healthcare company from the United States, launched a new liquid biopsy test named Labcorp Plasma Focus in June 2023. The test was designed to detect biomarkers associated with cancer in individuals with advanced or metastatic solid tumors. This test inspects the cell-free DNA (cfDNA) in a patient’s blood sample to generate a genomic profile of the patient’s tumor, thereby assisting oncologists in improving their patient’s healthcare management through designing uniquely tailored therapy plans. Hence, companies are pouring investments into the creation of cutting-edge products in the liquid biopsy sector.
Which Companies Are Contributing Significantly To The Liquid Biopsy Market Growth?
Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report
Which Region Is Leading Innovation In The Liquid Biopsy Market?
North America was the largest region in the liquid biopsy market in 2024. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=2815&type=smp
Browse Through More Reports Similar to the Global Liquid Biopsy Market 2025, By The Business Research Company
Biophotonics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report
Biopsy Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Ultrasound Systems Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
